Latest News for: haemonetics

Edit

Haemonetics Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance (Form 8-K) (Haemonetics Corporation)

Public Technologies 08 Aug 2025
) Haemonetics Reports First Quarter Fiscal 2026 Results; ... Boston, MA, August 7, 2025 - Haemonetics Corporation (NYSE ... Chris Simon, Haemonetics' CEO, stated ... ABOUT HAEMONETICS ... To learn more about Haemonetics, visit www.haemonetics.com.
Edit

Q1 2026 Haemonetics Corporation Earnings Release (Haemonetics Corporation)

Public Technologies 08 Aug 2025
[email protected] [email protected] ... [email protected] Haemonetics Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance ... To learn more about Haemonetics, visit https.//www.haemonetics.com.
Edit

Quarterly Report for Quarter Ending June 28, 2025 (Form 10-Q) (Haemonetics Corporation)

Public Technologies 08 Aug 2025
When used in this report, the terms "we," "us," "our," "Haemonetics" and the "Company" mean Haemonetics Corporation ... Haemonetics is a global medical ...
Edit

Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect

The Call 06 Aug 2025
Blood products company Haemonetics (NYSE ... Haemonetics beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $330.6 million, down 3.7% year on year ... Is Haemonetics a buy or sell ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Haemonetics Corporation)

Public Technologies 25 Jul 2025
HAEMONETICS CORP [HAE] 5 ... (1) The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan.
Edit

Proxy Results (Form 8-K) (Haemonetics Corporation)

Public Technologies 25 Jul 2025
The 2025 Annual Meeting of Shareholders of Haemonetics Corporation (the "Company") was held on Thursday, July 24, 2025 ... Haemonetics Corporation published this content on July 25, 2025, and is ...
Edit

Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know

The Call 11 Jul 2025
Is now the time to buy ICU Medical? Access our full analysis report here, it’s free.Medical Devices & Supplies - Specialty company Haemonetics (NYSE ... Is now the time to buy Haemonetics? Access our ...
Edit

Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) (Haemonetics Corporation)

Public Technologies 13 Jun 2025
HAEMONETICS CORP [HAE] 5 ... (1) The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan.
Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Haemonetics Corporation)

Public Technologies 06 Jun 2025
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, DC 20549. SCHEDULE 14A ... ☐ ... ☐ ... ☐ ... x ... ☐ ... HAEMONETICS CORPORATION ... Haemonetics Corporation published this content on June 06, 2025, and is solely responsible for the information contained herein.
Edit

Proxy Statement (Form DEF 14A) (Haemonetics Corporation)

Public Technologies 06 Jun 2025
... while recommending a group of companies that, in the aggregate, reflect Haemonetics' profile and position Haemonetics near the median of those companies based on certain size and valuation parameters.
Edit

Specialized Disclosure Report (Form SD) (Haemonetics Corporation)

Public Technologies 27 May 2025
This is the Conflict Minerals Report ("CMR") of Haemonetics Corporation ("Haemonetics," "we," "us," or "our") for the reporting period from January 1, ...
Edit

Annual Report for Fiscal Year Ending March 29, 2025 (Form 10-K) (Haemonetics Corporation)

Public Technologies 21 May 2025
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care ... $500.0 million of Haemonetics common stock over the next three years.
×